Summary
The global Human Plasma Derived Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Plasma-derived therapies are life-saving treatments used to treat various rare conditions such as primary immunodeficiencies including, common variable immunodeficiency, X-linked agammaglobulinaemia, X-linked hyperimmunoglobulin M syndrome, Wiskott-Aldrich syndrome, severe combined immunodeficiency and other combined immunodeficiencies.
Market Dynamics
High prevalence of primary immunodeficiencies is expected to propel growth of the global human plasma-derived therapeutics market over the forecast period. For instance, according to the study, ‘Systematic Review of Primary Immunodeficiency Diseases in Malaysia: 1979–2020’, published in Frontiers of Immunology in August 2020, the prevalence of rate of primary immunodeficiencies in Malaysia was 0.37 per 100,000 population.
Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global human plasma-derived therapeutics market. For instance, globally, as of 4:37pm CET, 3 December 2020, there have been 63,965,092 confirmed cases of COVID-19, including 1,488,120 deaths, reported to the World Health Organization. Moreover, initiatives to develop a potential plasma-derived therapy for treating COVID-19 disease is also expected to aid in growth of the market. For instance, in April 2020, Takeda Pharmaceutical Company Limited issued a press release stating Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring and Takeda Pharmaceutical to develop a potential plasma-derived therapy for treating COVID-19 disease.
Major players operating in the global human plasma-derived therapeutics market are focused on R&D to expand their product portfolio. For instance, in March 2020, Takeda Pharmaceutical Company Limited initiated the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19, while also studying whether Takeda’s currently marketed and pipeline products may be effective treatments for infected patients. SARS-CoV-2 is the virus that causes COVID-19.
Major players operating in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in April 2020, Emergent BioSolutions, Inc. entered into a formal partnership with the U.S. government to expedite development of a plasma-derived therapy for patients with coronavirus disease 2019 (COVID-19).
Key Takeaways
- High prevalence of primary immunodeficiencies is expected to propel growth of the global human plasma-derived therapeutics market over the forecast period
- Major players operating in the global human plasma-derived therapeutics market are focused on adopting M&A strategies to expand their product portfolio. For instance, in November 2020, Takeda Pharmaceutical Company Limited announced a share exchange where Takeda will be the wholly-owning parent company and Nihon Pharmaceutical Co., Ltd., Takeda’s consolidated subsidiary, will be the wholly-owned subsidiary effective April 1, 2021.
- Major players operating in the global human plasma-derived therapeutics market include, Alkahest, Baxter International, CSL Behring, Entegrion, Inc., Gammagard, Grifols, Kedrion, Octapharma, Prometic Life Sciences, Sanquin, Emergent BioSolutions, Inc., and Takeda Pharmaceutical Company Limited.
The Human Plasma Derived Therapeutics Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Human Plasma Derived Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Alkahest
- Baxter
- CSL Behring
- Entegrion, Inc.
- Gammagard
- Grifols
- Kedrion
- Octapharma
- Prometic Life Sciences
- Sanquin
- Shire
By the Product Type, the market is primarily segmented into:
- Albumin
- Immunoglobulin
- Clotting Factor
- Prothrombin Complex
- Others
By Applications, the market is segmented into:
- Hospital
- Clinic
- Research Center
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Human Plasma Derived Therapeutics Market Report:
- To assess the size of the market by value and volume
- Analyze the Human Plasma Derived Therapeutics Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Human Plasma Derived Therapeutics Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Human Plasma Derived Therapeutics Market
The Human Plasma Derived Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Human Plasma Derived Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Executive Summary
1 Industry Overview of Human Plasma-Derived Therapeutics
1.1 Definition of Human Plasma-Derived Therapeutics
1.2 Human Plasma-Derived Therapeutics Segment by Type
1.2.1 Global Human Plasma-Derived Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Prothrombin Complex
1.2.6 Others
1.3 Human Plasma-Derived Therapeutics Segment by Applications
1.3.1 Global Human Plasma-Derived Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Human Plasma-Derived Therapeutics Overall Market
1.4.1 Global Human Plasma-Derived Therapeutics Revenue (2014-2025)
1.4.2 Global Human Plasma-Derived Therapeutics Production (2014-2025)
1.4.3 North America Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.5 China Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.8 India Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Plasma-Derived Therapeutics
2.3 Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
2.4 Industry Chain Structure of Human Plasma-Derived Therapeutics
3 Development and Manufacturing Plants Analysis of Human Plasma-Derived Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Human Plasma-Derived Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Human Plasma-Derived Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Human Plasma-Derived Therapeutics Production and Capacity Analysis
4.2 Human Plasma-Derived Therapeutics Revenue Analysis
4.3 Human Plasma-Derived Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Human Plasma-Derived Therapeutics Regional Market Analysis
5.1 Human Plasma-Derived Therapeutics Production by Regions
5.1.1 Global Human Plasma-Derived Therapeutics Production by Regions
5.1.2 Global Human Plasma-Derived Therapeutics Revenue by Regions
5.2 Human Plasma-Derived Therapeutics Consumption by Regions
5.3 North America Human Plasma-Derived Therapeutics Market Analysis
5.3.1 North America Human Plasma-Derived Therapeutics Production
5.3.2 North America Human Plasma-Derived Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Human Plasma-Derived Therapeutics Import and Export
5.4 Europe Human Plasma-Derived Therapeutics Market Analysis
5.4.1 Europe Human Plasma-Derived Therapeutics Production
5.4.2 Europe Human Plasma-Derived Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Human Plasma-Derived Therapeutics Import and Export
5.5 China Human Plasma-Derived Therapeutics Market Analysis
5.5.1 China Human Plasma-Derived Therapeutics Production
5.5.2 China Human Plasma-Derived Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Human Plasma-Derived Therapeutics Import and Export
5.6 Japan Human Plasma-Derived Therapeutics Market Analysis
5.6.1 Japan Human Plasma-Derived Therapeutics Production
5.6.2 Japan Human Plasma-Derived Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Human Plasma-Derived Therapeutics Import and Export
5.7 Southeast Asia Human Plasma-Derived Therapeutics Market Analysis
5.7.1 Southeast Asia Human Plasma-Derived Therapeutics Production
5.7.2 Southeast Asia Human Plasma-Derived Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Human Plasma-Derived Therapeutics Import and Export
5.8 India Human Plasma-Derived Therapeutics Market Analysis
5.8.1 India Human Plasma-Derived Therapeutics Production
5.8.2 India Human Plasma-Derived Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Human Plasma-Derived Therapeutics Import and Export
6 Human Plasma-Derived Therapeutics Segment Market Analysis (by Type)
6.1 Global Human Plasma-Derived Therapeutics Production by Type
6.2 Global Human Plasma-Derived Therapeutics Revenue by Type
6.3 Human Plasma-Derived Therapeutics Price by Type
7 Human Plasma-Derived Therapeutics Segment Market Analysis (by Application)
7.1 Global Human Plasma-Derived Therapeutics Consumption by Application
7.2 Global Human Plasma-Derived Therapeutics Consumption Market Share by Application (2014-2019)
8 Human Plasma-Derived Therapeutics Major Manufacturers Analysis
8.1 Alkahest
8.1.1 Alkahest Human Plasma-Derived Therapeutics Production Sites and Area Served
8.1.2 Alkahest Product Introduction, Application and Specification
8.1.3 Alkahest Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Baxter
8.2.1 Baxter Human Plasma-Derived Therapeutics Production Sites and Area Served
8.2.2 Baxter Product Introduction, Application and Specification
8.2.3 Baxter Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 CSL Behring
8.3.1 CSL Behring Human Plasma-Derived Therapeutics Production Sites and Area Served
8.3.2 CSL Behring Product Introduction, Application and Specification
8.3.3 CSL Behring Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Entegrion, Inc.
8.4.1 Entegrion, Inc. Human Plasma-Derived Therapeutics Production Sites and Area Served
8.4.2 Entegrion, Inc. Product Introduction, Application and Specification
8.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Gammagard
8.5.1 Gammagard Human Plasma-Derived Therapeutics Production Sites and Area Served
8.5.2 Gammagard Product Introduction, Application and Specification
8.5.3 Gammagard Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Grifols
8.6.1 Grifols Human Plasma-Derived Therapeutics Production Sites and Area Served
8.6.2 Grifols Product Introduction, Application and Specification
8.6.3 Grifols Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Kedrion
8.7.1 Kedrion Human Plasma-Derived Therapeutics Production Sites and Area Served
8.7.2 Kedrion Product Introduction, Application and Specification
8.7.3 Kedrion Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Octapharma
8.8.1 Octapharma Human Plasma-Derived Therapeutics Production Sites and Area Served
8.8.2 Octapharma Product Introduction, Application and Specification
8.8.3 Octapharma Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Prometic Life Sciences
8.9.1 Prometic Life Sciences Human Plasma-Derived Therapeutics Production Sites and Area Served
8.9.2 Prometic Life Sciences Product Introduction, Application and Specification
8.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Sanquin
8.10.1 Sanquin Human Plasma-Derived Therapeutics Production Sites and Area Served
8.10.2 Sanquin Product Introduction, Application and Specification
8.10.3 Sanquin Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Shire
9 Development Trend of Analysis of Human Plasma-Derived Therapeutics Market
9.1 Global Human Plasma-Derived Therapeutics Market Trend Analysis
9.1.1 Global Human Plasma-Derived Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Human Plasma-Derived Therapeutics Regional Market Trend
9.2.1 North America Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.2 Europe Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.3 China Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.4 Japan Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.6 India Human Plasma-Derived Therapeutics Forecast 2019-2025
9.3 Human Plasma-Derived Therapeutics Market Trend (Product Type)
9.4 Human Plasma-Derived Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Human Plasma-Derived Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Table
List of Tables and Figures
Figure Picture of Human Plasma-Derived Therapeutics
Table Global Human Plasma-Derived Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Production Market Share by Types in 2018
Figure Albumin Product Picture
Figure Immunoglobulin Product Picture
Figure Clotting Factor Product Picture
Figure Prothrombin Complex Product Picture
Figure Others Product Picture
Table Global Human Plasma-Derived Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Research Center
Figure Global Human Plasma-Derived Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Production (K Pcs) (2014-2025)
Figure North America Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure China Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure India Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Table Human Plasma-Derived Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Human Plasma-Derived Therapeutics in 2018
Figure Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
Figure Industry Chain Structure of Human Plasma-Derived Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Human Plasma-Derived Therapeutics Manufacturing Plants Distribution
Table Human Plasma-Derived Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Human Plasma-Derived Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Human Plasma-Derived Therapeutics Production Share by Manufacturers in 2018
Table Human Plasma-Derived Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Human Plasma-Derived Therapeutics Revenue Share by Manufacturers in 2018
Table Human Plasma-Derived Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Human Plasma-Derived Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Human Plasma-Derived Therapeutics Production Market Share by Regions 2014-2019
Figure Global Human Plasma-Derived Therapeutics Production Market Share by Regions in 2018
Table Global Human Plasma-Derived Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions in 2018
Table Global Human Plasma-Derived Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Human Plasma-Derived Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Human Plasma-Derived Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Human Plasma-Derived Therapeutics Market Share by Application (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Alkahest Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Alkahest Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Alkahest Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Baxter Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Baxter Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Baxter Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Baxter Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Main Business and Markets Served
Table CSL Behring Human Plasma-Derived Therapeutics Production Sites and Area Served
Table CSL Behring Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table CSL Behring Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure CSL Behring Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Gammagard Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Gammagard Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Gammagard Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Gammagard Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Grifols Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Grifols Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Grifols Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Grifols Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Kedrion Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Kedrion Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Kedrion Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Kedrion Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Octapharma Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Octapharma Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Octapharma Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Octapharma Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Sanquin Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Sanquin Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Sanquin Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Sanquin Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Shire Human Plasma-Derived Therapeutics Production Sites and Area Served
Figure Global Human Plasma-Derived Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Human Plasma-Derived Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Human Plasma-Derived Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Human Plasma-Derived Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Human Plasma-Derived Therapeutics by Application (2019-2025)
Table Human Plasma-Derived Therapeutics Distributors List
Table Human Plasma-Derived Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
